Quick Facts
| Property | Value |
|---|---|
| Category | Anxiolytic / Nootropic Peptide |
| Risk Level | Moderate/High |
| Administration | Intranasal or Subcutaneous |
| Typical Frequency | 1–3 Times Daily |
| Estimated Half-Life | Short Plasma Half-Life / Longer Neurological Effects |
| Primary Research Interest | Anxiety Reduction / Stress Resilience / Cognitive Clarity |
This material is provided strictly for educational and informational purposes related to peptide research and experimental nootropic compounds. Selank is a biologically active peptide capable of altering neurological signaling pathways involving anxiety regulation, stress response, and neurochemical balance. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.
1. Intranasal Administration Protocol
- Vial Size: 10 mg
- Dilutant Type: BAC Water or Sterile Saline
- Initial Vial Reconstitution: Add 3 mL to the peptide vial
- Transfer Instructions: Withdraw the entire vial contents and transfer into a nasal spray bottle
- Final Spray Bottle Dilution: Add an additional 11 mL of dilutant for a total final volume of 14 mL
- Final Concentration: 0.714 mg/mL
- Spray Bottle Type: 30 mL metered spray bottle delivering approximately 0.175 mL per spray
At this concentration:
• 1 spray (0.175 mL) ≈ 0.125 mg (125 mcg)
• 2 sprays total (1 per nostril) = 250 mcg total dose
- Typical Delivered Amount: 125 mcg per nostril (250 mcg total dose), three times daily
- Frequency: Three times daily
- Cycle Length: 2 weeks on / 2 weeks off. Do not exceed 4 weeks on in a row to avoid dopaminergic burnout.
- Special Notes: High doses may actually worsen outcomes. Excessive dosing may cause emotional flattening, brain fog, reduced motivation, fatigue, or apathy. Use caution stacking Selank with benzodiazepines, sedative antihistamines, alcohol, high-dose cannabinoids, or heavy GABAergic supplements.
2. Subcutaneous Administration Protocol
- Vial Size: 10 mg
- Dilutant Type: BAC Water
- Amount of Dilutant Added: 2.5 mL
- Final Concentration: 4.00 mg/mL
At this concentration:
• 200 mcg = 0.050 mL (5.0 units)
• 1000 mcg = 0.250 mL (25.0 units)
- Typical Delivered Amount: 200–1000 mcg SQ in the morning upon waking
- Frequency: Once daily in the morning
- Cycle Length: 2 weeks on / 2 weeks off. Do not exceed 4 weeks on in a row to avoid dopaminergic burnout.
- Special Notes: Subcutaneous use is considered highly experimental. There is little evidence showing that it is nearly as effective as intranasal use. Metered nasal spray bottles can easily be purchased online, and the common consensus favors the intranasal route.
3. Summary
Selank is an experimental anxiolytic nootropic peptide researched for its potential effects on anxiety reduction, stress resilience, mood stabilization, and cognitive clarity.
Research interest in Selank commonly centers around calming effects without heavy sedation, along with possible cognitive and neurochemical support.
4. Mechanism of Action
Selank is believed to influence neurotransmitter systems involving GABA, serotonin, dopamine, and neurotrophic signaling pathways.
- Potential anxiolytic signaling
- Stress resilience modulation
- Possible enhancement of cognitive clarity
- Potential mood stabilization support
- Neurochemical balancing effects
The compound is often discussed as a calming nootropic with less sedation than traditional anxiolytic medications.
5. Potential Benefits
- Potential anxiety reduction
- Improved stress resilience
- Enhanced emotional stability
- Possible cognitive clarity improvements
- Reduced mental fatigue
- Potential focus enhancement without strong stimulation
6. Potential Risks / Side Effects
Moderate/High
- Emotional flattening
- Brain fog
- Fatigue
- Apathy
- Reduced motivation
- Potential neurological adaptation with excessive use
- Limited long-term human safety data
7. Half-Life
Selank is commonly discussed as having a relatively short circulating plasma half-life.
However, downstream neurological and neurochemical signaling effects may persist significantly longer than measurable plasma levels.
8. Storage Information
- Store refrigerated before and after reconstitution
- Protect from direct light exposure
- Avoid repeated freeze-thaw cycles
- Maintain sterile handling practices during preparation
9. Contraindications / Warnings
- Use alongside sedative medications
- Severe depressive disorders
- Pregnancy or breastfeeding
- Severe psychiatric disorders
- Known hypersensitivity to peptide compounds
10. Research References
- PubMed
- NIH Publications
- Nootropic and anxiolytic peptide literature
- Peer-reviewed neurology journals
CKF Tide Tables 